Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis

References

• WHO Western Pacific. Hand, foot, and mouth disease. WHO; 2019 April 23 [accessed 2020Mar 25]. https://www.who.int/westernpacific/emergencies/surveillance/archives/hand-foot-and-mouth-disease.
   Google Scholar
• Cox B, Hand LF. Foot, and mouth diseasehand, foot, and mouth diseasehand, foot, and mouth disease. JAMA. 2018;320(23):2492. doi:10.1001/jama.2018.17288.
   PubMedGoogle Scholar
• Department of Disease Prevention and Control. Epidemic situation of notifiable infectious diseases in China (in Chinese). National Health Commission of the People’s Republic China; 2019 April 24 [accessed 2020 Mar 25]. http://www.nhc.gov.cn/wjw/rdts/list.shtml.
   Google Scholar
• Zhang R, Dai T, Jia X, Li Y. Comprehensive evaluation of health effect of notifiable infectious diseases in China (in Chinese). China Med Her. 2015;12(12):50–53.
   Google Scholar
• Health CFP. Hand, foot and mouth disease. Hong Kong, China: Department of Health; 2019 June 27 [accessed 2020 Mar 25]. https://www.chp.gov.hk/en/healthtopics/content/24/23.html.
   Google Scholar
• Shimizu H, Nakashima K. Surveillance of hand, foot, and mouth disease for a vaccine. Lancet Infect Dis. 2014;14(4):262–63. doi:10.1016/S1473-3099(13)70330-X.
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016:1–8. doi:10.1586/14760584.2016.1138862.
   Web of Science ®Google Scholar
• Gao E, Wu S, Xu Q, Zeng Y, Tan N, He S, Yang Y, Wei J. Enterovirus type 71‑immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro. Exp Ther Med. 2019;18:332–41. doi:10.3892/etm.2019.7529.
   PubMed Web of Science ®Google Scholar
• Yang T, Li H, Yue L, Song X, Xie T, Ma S, Meng H, Zhang Y, He X, Long R, et al. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro. Virol J. 2017;14(1):206. doi:10.1186/s12985-017-0872-8.
   PubMed Web of Science ®Google Scholar
• Huang J, Liao Q, Ooi MH, Cowling BJ, Chang Z, Wu P, Liu F, Li Y, Luo L, Yu S, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015. Emerg Infect Dis. 2018;24(3):432–42. doi:10.3201/eid2403.171303.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu Y, Li S, Zhao H, Lin Q, Yu H, Huang X, Zheng Q, Cheng T, Xia N. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Vaccine. 2016;34(48):5938–45. doi:10.1016/j.vaccine.2016.10.018.
   PubMed Web of Science ®Google Scholar
• Liang S Cross-protection of Enterovirus 71 vaccine and construction of its gene recombinant mycobacterium smegmatis (in Chinese) [dissertation]. Guilin (China): Guilin Medical University; 2018.
   Google Scholar
• Zhu F, Meng F, Li J, Li X, Mao Q, Tao H, Zhang Y, Yao X, Chu K, Chen Q, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre,randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–32. doi:10.1016/S0140-6736(13)61049-1.
   PubMed Web of Science ®Google Scholar
• Wang W, Song J, Wang J, Li Y, Deng H, Li M, Gao N, Zhai S, Dang S, Zhang X, et al. Cost-effectiveness of a national enterovirus 71 vaccination program in China. Plos Neglect Trop D. 2017;11(9):e5899. doi:10.1371/journal.pntd.0005899.
   PubMed Web of Science ®Google Scholar
• Comprehensive statistical office. Statistical yearbook of Guangdong. Statistics Bureau of Guangdong; 2019 Sep 29 [accessed 2020 Mar 25]: http://stats.gd.gov.cn/gdtjnj/index.html.
   Google Scholar
• Hohle M, Siedler A, Bader HM, Ludwig M, Heininger U, Von Kries R. Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect. 2011;139(11):1710–19. doi:10.1017/S0950268810002815.
   PubMed Web of Science ®Google Scholar
• Kiyono K. Establishing a direct connection between detrended fluctuation analysis and Fourier analysis. Phys Rev E Stat Nonlin Soft Matter Phys. 2015;92(4):42925. doi:10.1103/PhysRevE.92.042925.
   Web of Science ®Google Scholar
• Experts from China CDC. Core information of prevention and control of hand, foot and mouth disease (in Chinese). China CDC; 2018 Mar 26 [accessed 2020 Mar 25]. http://www.chinacdc.cn/jkzt/crb/bl/szkb/zstd/201803/t20180326_159976.html.
   Google Scholar
• Li Y, Zhou Y, Cheng Y, Wu P, Zhou C, Cui P, Song C, Liang L, Wang F, Qiu Q, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019;3(10):697–704. doi:10.1016/S2352-4642(19)30185-3.
   PubMedGoogle Scholar
• Wang X, An Z, Huo D, Jia L, Li J, Yang Y, Liang Z, Wang Q, Wang H. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Hum Vacc Immunother. 2019;15(5):1183–90. doi:10.1080/21645515.2019.1581539.
   PubMed Web of Science ®Google Scholar
• InterNations GO. The Chinese education system. InterNations GO; 2020 Jan 30 [accessed 2020 Mar 25]. https://www.internations.org/go/moving-to-china/education.
   Google Scholar
• Du Z, Zhang W, Zhang D, Yu S, Hao Y. Epidemiological characteristics of severe cases of hand, foot, and mouth disease in Guangdong, China. Biostatistics Epidemiol. 2018;2(1):99–114. doi:10.1080/24709360.2018.1469809.
   Google Scholar
• Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. New Engl J Med. 2014;370(9):818–28. doi:10.1056/NEJMoa1304923.
   PubMed Web of Science ®Google Scholar